Aceragen, Inc. (ACGN) vs Palatin Technologies, Inc. (PTN)

Aceragen, Inc. and Palatin Technologies, Inc. are both Biotechnology companies. Aceragen, Inc. and Palatin Technologies, Inc. are of similar size ($17.5M and $17.1M). Aceragen, Inc. has negative trailing earnings, so its P/E is not meaningful; Palatin Technologies, Inc. trades at 2.4×. Aceragen, Inc. grew revenue faster over the last twelve months: 1,226.3% against 86.5%. Palatin Technologies, Inc. has the higher net margin (−47.2% vs −467.5%) and the lower return on invested capital (−942.3% vs −135.4%). Across the 17 metrics below, Palatin Technologies, Inc. leads on 11 and Aceragen, Inc. on 6.

Valuation

Metric ACGN PTN Biotechnology median
P/E n/m 2.43 7.88
P/S 1.52 2.99 11.47
P/B 0.83 3.73 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 4.09 2.23 10.73
Earnings yield (181.40%) 41.20% (28.84%)
Free cash flow yield (250.88%) (37.93%) (23.03%)

Profitability

Metric ACGN PTN Biotechnology median
Gross margin 83.46% 100.00% 65.16%
Operating margin (503.92%) (49.26%) 0.00%
Net margin (467.53%) (47.22%) 0.00%
Free cash flow margin (339.17%) (113.25%) 0.00%
Return on equity (169.66%) (297.25%) (57.72%)
Return on assets (75.58%) (73.72%) (49.22%)
Return on invested capital (135.35%) (942.30%) 0.00%

Growth

Metric ACGN PTN Biotechnology median
Revenue growth (TTM) 1,226.28% 86.46% 5.64%
EPS growth (last fiscal year) (121.58%) 68.15% —
Revenue growth, 5-year CAGR 81.19% (40.52%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ACGN PTN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.32 5.04 4.73
Net debt to EBITDA 0.43 0.15 0.96

Dividend

Metric ACGN PTN Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ACGN PTN Biotechnology median
Market cap 17.15m 17.49m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack